Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.

Autor: Linde MH; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Fan AC; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Köhnke T; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Trotman-Grant AC; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Gurev SF; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Phan P; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Zhao F; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Haddock NL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California., Nuno KA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Gars EJ; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University, Stanford, California., Stafford M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Marshall PL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California., Dove CG; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Linde IL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University, Stanford, California., Landberg N; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Miller LP; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Majzner RG; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Zhang TY; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Majeti R; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.

Publikováno v: Cancer discovery [Cancer Discov] 2023 May 04; Vol. 13 (5), pp. 1164-1185.